Hypothesis: immunologic rationale for the therapy of membranous lupus nephropathy.
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000917:Antibody Formation; D004247:DNA / Q000276:immunology; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D009393:Nephritis / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D011241:Prednisone / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D004247:DNA; D011241:Prednisone